BRYNJELSEN SEAN (President & CEO) sold 6.8% of their position (210K shares) of ETON PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $3.59M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 5 sales
Filed: 6/5/2025ACC: 0001437749-25-019583
DirectorOfficer· President & CEO
Since Nov 2018
-210K
Net shares
Net seller
$3.59M
Total sold
5
Open market trades
0B · 5S
5
Total transactions
210K disposed
Non-Derivative Transactions5
Common Stock
Direct
Shares
−60.95K
Price / share
$17.38
Trade value
$1.06M
% of position
2.0%
6/3/2025
3.08M→3.02M
Common Stock
Direct
Shares
−8.65K
Price / share
$18.38
Trade value
$159.08K
% of position
0.3%
6/3/2025
3.02M→3.01M
Common Stock
Direct
Shares
−400.00
Price / share
$19.02
Trade value
$7.61K
% of position
0.0%
6/3/2025
3.01M→3.01M
Common Stock
Direct
Shares
−70K
Price / share
$17.00
Trade value
$1.19M
% of position
2.3%
6/4/2025
3.01M→2.94M
Common Stock
Direct
Shares
−70K
Price / share
$16.81
Trade value
$1.18M
% of position
2.4%
6/5/2025
2.94M→2.87M
Total
Net shares
−210K
Net value
-$3.59M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/3/2025 | S · Sale | −60.95K | $17.38 | $1.06M | 2.0% | 3.08M | 3.02M |
| Common Stock Direct | 6/3/2025 | S · Sale | −8.65K | $18.38 | $159.08K | 0.3% | 3.02M | 3.01M |
| Common Stock Direct | 6/3/2025 | S · Sale | −400.00 | $19.02 | $7.61K | 0.0% | 3.01M | 3.01M |
| Common Stock Direct | 6/4/2025 | S · Sale | −70K | $17.00 | $1.19M | 2.3% | 3.01M | 2.94M |
| Common Stock Direct | 6/5/2025 | S · Sale | −70K | $16.81 | $1.18M | 2.4% | 2.94M | 2.87M |
| Total | −210K | -$3.59M | ||||||
Derivative Transactions0
No derivative transactions reported